Interferon beta-1b in the treatment of patients with active relapsing-remitting or secondary progressive multiple sclerosis:: results of a Markov disease model for Sweden and the UK

被引：0
|
作者：
Kobelt, G
Jönsson, L
Fredrikson, S
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Stockholm Hlth Econ Consulting, Stockholm, Sweden
[3] Huddinge Univ Hosp, Stockholm, Sweden
来源：
JOURNAL OF NEUROLOGY | 2004年 / 251卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [31] Interferon beta-1b inhibits reactive oxygen species production in peripheral blood monocytes of patients with relapsing-remitting multiple sclerosis
    Lucas, M
    Sánchez-Soliño, O
    Solano, F
    Izquierdo, G
    NEUROCHEMISTRY INTERNATIONAL, 1998, 33 (02) : 101 - 102
  • [32] Serial whole-brain magnetization transfer imaging in patients with relapsing-remitting multiple sclerosis at baseline and during treatment with interferon beta-1b
    Richert, ND
    Ostuni, JL
    Bash, CN
    Duyn, JH
    McFarland, HF
    Frank, JA
    AMERICAN JOURNAL OF NEURORADIOLOGY, 1998, 19 (09) : 1705 - 1713
  • [33] Impact of discontinuing interferon beta in patients with relapsing-remitting multiple sclerosis
    Agiela, Mabroka I. M.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : NP5 - NP5
  • [34] Rationale for early treatment with interferon beta-1a in relapsing-remitting multiple sclerosis
    Munschauer, FE
    Stuart, WH
    CLINICAL THERAPEUTICS, 1997, 19 (05) : 868 - 882
  • [35] Interferon Beta 1-B in verbal memory functioning of patients with relapsing-remitting multiple sclerosis
    Selby, MJ
    Ling, N
    Williams, JM
    Dawson, A
    PERCEPTUAL AND MOTOR SKILLS, 1998, 86 (03) : 1099 - 1106
  • [36] Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
    Jankovic, Slobodan M.
    JOURNAL OF INFLAMMATION RESEARCH, 2010, 3 : 25 - 31
  • [37] Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
    Paolicelli, Damiano
    Direnzo, Vita
    Trojano, Maria
    BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 369 - 376
  • [38] Value of cytokine gene polymorphisms as prognostic markers of efficacy of interferon beta-1b (Betaferon®) in relapsing-remitting multiple sclerosis
    Guerrero, A. L.
    Arranz, E.
    Perez, D.
    Garrote, J. A.
    Mendoza, A.
    Lopez-Al-burquerque, J. T.
    Caminero, A. B.
    Moran, J. C.
    JOURNAL OF NEUROLOGY, 2006, 253 : 142 - 143
  • [39] Interferon beta-1b in early relapsing-remitting multiple sclerosis: 2-year data from the BEST Study
    Kappos, L
    JOURNAL OF NEUROLOGY, 2005, 252 : 131 - 132
  • [40] Comparison of permanent black hole lesion number in relapsing-remitting multiple sclerosis with interferon beta-1b to glatiramer acetate
    Rocca, M. A.
    Camesasca, Fabiano
    Cook, Stuart
    Comi, Giancarlo
    Goodin, Douglas S.
    O'Connor, Paul W.
    Jeffrey, Douglas
    Hartung, Hans-Peter
    Arnason, Barry G. W.
    Kappos, Ludwig
    Wolinsky, Jerry
    Pohl, Christoph
    Beckmann, Karola
    Croze, Ed
    Sandbrink, Rupert
    Arnold, Douglas L.
    Cutter, Gary
    Bogumil, Timon
    Knappertz, Volker
    Filippi, Massimo
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (08) : 1017 - 1017
12345